JoVE Logo

Zaloguj się

Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological activity, conjugation effectively ends drug action and facilitates safe excretion. Phase I reactions often prepare molecules for this process by introducing functional groups, making conjugation a crucial step in comprehensive drug metabolism.

Conjugation reactions are highly specific, occurring between distinct functional groups on the drug or metabolite and the conjugating agent. These agents, such as glucuronic acid and sulfate, are abundant in the body, making them readily available for these reactions. The capacity for conjugation varies among different drugs and functional groups, with some drugs being more prone to conjugation than others. The formation of conjugates through phase II reactions significantly increases their molecular weight, boosting their water solubility and facilitating their excretion. Conjugates are typically expelled from the body through renal excretion via urine or biliary excretion via bile.

Tagi

Phase II ConjugationBiotransformationDrug DetoxificationGlucuronic AcidSulfateGlycineConjugation ReactionsEnzyme CatalysisInactive MetabolitesWater soluble FormsDrug MetabolismPharmacological ActivityFunctional GroupsRenal Excretion

Z rozdziału 5:

article

Now Playing

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

108 Wyświetleń

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

161 Wyświetleń

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

210 Wyświetleń

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

109 Wyświetleń

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

44 Wyświetleń

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

152 Wyświetleń

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

46 Wyświetleń

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

142 Wyświetleń

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

107 Wyświetleń

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

89 Wyświetleń

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

120 Wyświetleń

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

72 Wyświetleń

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

25 Wyświetleń

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

112 Wyświetleń

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

71 Wyświetleń

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone